Abstract

Metastatic lesions in the small bowel are more common than primary lesions and account for 0.5% of all small intestinal malignancies. Most common is malignant melanoma followed by adenocarcinoma from pancreas, colon or stomach; and squamous cell carcinoma from lung, cervix, esophagus, skin, penis, ovary, pancreas and gallbladder. Gastrointestinal involvement as a manifestation of metastatic squamous cell carcinoma with unknown primary is relatively uncommon with very few being reported in the literature. The most common presenting symptom of small bowel lesions is subacute or acute obstruction and less commonly, bowel perforation, abdominal pain or hemorrhage. It is a diagnosis which dawns upon after the surgery when histopathology proves the same and therefore a thorough workup to establish the primary starts after the bailout procedure. Its clinical course is aggressive, characterized by a short preclinical history, resistance to chemotherapy, and overall dismal prognosis with a median life expectancy of 6 to 9 months as it represents a disseminated disease.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.